Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from SELLAS Life Sciences Group ( (SLS) ).
On January 10, 2025, SELLAS Life Sciences Group, Inc. announced amendments to the Change in Control Severance Agreements for two key executives, Dragan Cicic and John Burns, to include 15 months of severance pay upon termination due to a change of control. This move reflects the company’s efforts to ensure stability and support for its leadership team during potential transitions, which could have implications for its operational continuity and strategic positioning.
More about SELLAS Life Sciences Group
YTD Price Performance: -9.44%
Average Trading Volume: 1,189,530
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $65.35M
Find detailed analytics on SLS stock on TipRanks’ Stock Analysis page.
